ADVFN Logo

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for charts Cadastre-se para gráficos em tempo real, ferramentas de análise e preços.

ESPR Esperion Therapeutics Inc

2,6808
0,0608 (2,32%)
28 Mar 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Esperion Therapeutics Inc ESPR NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
0,0608 2,32% 2,6808 20:53:15
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,64 2,54 2,80 2,68 2,62
mais cotações »

Notícias Recentes

Data Hora Fonte Título
26/03/202409:00GLOBEEsperion to Participate in 23rd Annual Needham Virtual..
25/03/202417:00GLOBEEsperion Announces Data from CLEAR Outcomes Sub-Groups as..
22/03/202419:26BWU.S. FDA Approves Broad New Labels for Esperion’s NEXLETOL®..
22/03/202416:10GLOBEU.S. FDA Approves Broad New Labels for NEXLETOL® and..
22/03/202412:04GLOBECHMP Issues Positive Opinions For Both Bempedoic Acid And..
27/02/202408:00GLOBEEsperion Reports Fourth Quarter and Full Year 2023 Financial..
16/02/202418:30GLOBEEsperion Announces Inducement Grants Under NASDAQ Listing..
13/02/202410:00GLOBEEsperion to Report Fourth Quarter and Full Year 2023..
01/02/202416:00GLOBERFK, Esperion Therapeutics Announce 2024 Promotional..
23/01/202418:00GLOBEEsperion Announces Closing of Public Offering of Common..
18/01/202423:15GLOBEEsperion Announces Pricing of $85.1 Million Public Offering..
18/01/202418:00GLOBEEsperion Announces Proposed Public Offering of Common Stock
03/01/202417:15BWEsperion e Daiichi Sankyo Europe annunciano un emendamento..
03/01/202415:54BWEsperion et Daiichi Sankyo Europe annoncent une révision de..
03/01/202412:07BWEsperion und Daiichi Sankyo Europe geben Anpassung ihrer..
03/01/202409:00BWEsperion and Daiichi Sankyo Europe Announce $125 Million..
18/12/202310:00GLOBEEsperion to Participate in 42nd Annual J.P. Morgan..
13/12/202318:46DJNEsperion Therapeutics' Nexletol, Nexlizet Updates Get FDA..
13/12/202318:00GLOBEU.S. FDA Updates LDL-C Lowering Indication for Esperion’s..
13/11/202312:30GLOBEEsperion Presents CLEAR Outcomes Analysis of Inflammation as..
11/11/202313:00GLOBEPartners Announce TRANSFORM Trial to Evaluate Personalized..
09/11/202318:30GLOBEEsperion Announces Inducement Grants Under NASDAQ Listing..
07/11/202308:00GLOBEEsperion Reports Third Quarter 2023 Financial Results
31/10/202309:00GLOBEEsperion to Participate in Jefferies London Healthcare..
24/10/202309:00GLOBEEsperion to Report Third Quarter 2023 Financial Results on..
12/09/202311:15GLOBEAmerican College of Cardiology Program to Increase..
28/08/202309:00GLOBEEsperion to Participate in H.C. Wainwright 25th Annual..
26/08/202312:00GLOBEEsperion Presents Two CLEAR Outcomes Study Late-Breakers at..
11/08/202309:00GLOBETwo CLEAR Outcomes Study Late-Breakers Accepted at European..
08/08/202317:15GLOBEEsperion Announces Inducement Grants Under NASDAQ Listing..
01/08/202307:00GLOBEEsperion Reports Second Quarter 2023 Financial Results
24/07/202309:00GLOBEEsperion to Participate in BTIG Virtual Biotechnology..
17/07/202307:00GLOBEEsperion to Report Second Quarter 2023 Financial Results on..
07/07/202309:00GLOBEEsperion to Present Additional Data from the CLEAR Outcomes..
28/06/202309:00GLOBEEsperion Announces Submission of Application for Expanded..
24/06/202315:30GLOBEEsperion Presents Results from CLEAR Outcomes Primary..
15/06/202315:30GLOBEEsperion Presents Results from New Analysis on..
08/06/202309:00GLOBEEsperion to Present New Key Science at the American Diabetes..
05/06/202309:00GLOBEEsperion to Present Additional Analyses from the Landmark..
01/06/202309:00GLOBEEsperion Announces Submission of Supplemental New Drug..
25/05/202317:30GLOBEEsperion Announces Adjournment of 2023 Annual Meeting of..
24/05/202309:00GLOBEEsperion to Participate in Jefferies Healthcare Conference
12/05/202317:30GLOBEEsperion Announces Inducement Grants Under NASDAQ Listing..
09/05/202308:00GLOBEEsperion Reports First Quarter 2023 Financial Results
04/05/202309:30GLOBEEsperion Retains Gibson Dunn to Secure $300 Million Payment..
01/05/202309:00GLOBEEsperion to Participate in JMP Securities Life Sciences..
27/04/202309:00GLOBEEsperion to Participate in Bank of America Securities 2023..
25/04/202309:00GLOBEEsperion to Report First Quarter 2023 Financial Results May..
19/04/202309:42GLOBEEsperion Announces Co-Promotion Agreement With Currax..
03/04/202309:00GLOBEEsperion to Participate in Needham 22nd Annual Virtual..

Seu Histórico Recente

Delayed Upgrade Clock